INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
25/06/2026
Voltar para busca
Dado oficial do USPTO
BASALIN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
25/06/2026
Tipo de marca
Mista
Classes Nice
5
Data de depósito
25/07/2013
Data de registro
07/10/2014
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/04/2025
Última transação
25/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
Tongzhou D., Beijing, CN
Examinador
JACKSON, STEVEN W
Localização atual
Historical data usage
Titulares e representantes
Titulares
Gan & Lee Pharmaceuticals.
Gan & Lee Pharmaceuticals Ltd.
Representantes
Andrew T. Rissler Patel & Almeida, P.C.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicines for human purposesinsulin; raw material medicineinsulin; Biomedicine for treating diabetes; pharmaceutical preparations for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Biological preparations for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesdiabetesanti-infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines cognitive disorders; chemical preparations for medical purposesfor the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Chemical preparations for pharmaceutical purposesfor the treatment of endocrine related diseases and disorders; Pharmaceutical preparationsinsulin for injection; dietetic substancesdietetic sugarpasta and crackers adapted for medical use; drugsanti-diabetic pharmaceuticals for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
07/12/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
19/06/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
07/04/2025
71AG
REGISTERED-SEC.71 ACCEPTED
07/04/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/04/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
24/01/2025
ES71
TEAS SECTION 71 RECEIVED
07/11/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
07/10/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/05/2023
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
03/11/2021
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
27/09/2021
INPC
INVALIDATION PROCESSED
27/09/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/09/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
11/01/2021
71AG
REGISTERED-SEC.71 ACCEPTED
11/01/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/01/2021
ES71
TEAS SECTION 71 RECEIVED
02/10/2020
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/10/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/04/2017
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
02/06/2015
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
01/06/2015
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/04/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/03/2015
FIMP
FINAL DISPOSITION PROCESSED
11/03/2015
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/01/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
07/10/2014
GPNX
NOTIFICATION PROCESSED BY IB
22/07/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/07/2014
PUBO
PUBLISHED FOR OPPOSITION
22/07/2014
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/07/2014
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/07/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/07/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
19/06/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/06/2014
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
18/06/2014
ALIE
ASSIGNED TO LIE
11/06/2014
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/12/2013
GNSL
LETTER OF SUSPENSION E-MAILED
11/12/2013
CNSL
SUSPENSION LETTER WRITTEN
11/12/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/12/2013
RFNT
REFUSAL PROCESSED BY IB
10/12/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/12/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/11/2013
RFRR
REFUSAL PROCESSED BY MPU
18/11/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/11/2013
CNRT
NON-FINAL ACTION WRITTEN
14/11/2013
DOCK
ASSIGNED TO EXAMINER
08/11/2013
MAFR
APPLICATION FILING RECEIPT MAILED
15/10/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/10/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/10/2013
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BASALIN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.